|
| 30420699 | Pathway-based subnetworks enable cross-disease biomarker discovery. | Nat Commun | 2018 |
| 29917140 | Predictive Biomarkers for Endocrine Therapy: Retrospective Study in Tamoxifen and Exemestane Adjuvant Multinational (TEAM) Trial. | J Natl Cancer Inst | 2018 |
| 28649643 | Molecular stratification of early breast cancer identifies drug targets to drive stratified medicine. | NPJ Breast Cancer | 2017 |
| 26717057 | Validation of the IHC4 Breast Cancer Prognostic Algorithm Using Multiple Approaches on the Multinational TEAM Clinical Trial. | Arch Pathol Lab Med | 2016 |
| 24271056 | Effect of prior chemotherapy regimens on the efficacy of endocrine therapy within a German cohort of the TEAM trial. | J Cancer Res Clin Oncol | 2014 |
| 25071141 | Mutational analysis of PI3K/AKT signaling pathway in tamoxifen exemestane adjuvant multinational pathology study. | J Clin Oncol | 2014 |
| 24091623 | Do type 1 receptor tyrosine kinases inform treatment choice? A prospectively planned analysis of the TEAM trial. | Br J Cancer | 2013 |
| 22321061 | Effects of exemestane and tamoxifen on hormone levels within the Tamoxifen Exemestane Adjuvant Multicentre (TEAM) trial: results of a German substudy. | Climacteric | 2012 |
| 22993340 | Compliance, analgesic use and side-effect protection within a German cohort of the TEAM trial. | Anticancer Res | 2012 |
| 23045591 | Mammostrat as an immunohistochemical multigene assay for prediction of early relapse risk in the tamoxifen versus exemestane adjuvant multicenter trial pathology study. | J Clin Oncol | 2012 |
| 22467902 | Correlation of treatment-emergent adverse events and clinical response to endocrine therapy in early breast cancer: a retrospective analysis of the German cohort of TEAM. | Ann Oncol | 2012 |
| 21247627 | Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial. | Lancet | 2011 |
| 21422407 | Estrogen receptor and progesterone receptor as predictive biomarkers of response to endocrine therapy: a prospectively powered pathology study in the Tamoxifen and Exemestane Adjuvant Multinational trial. | J Clin Oncol | 2011 |
| 20393978 | Variations in locoregional therapy in postmenopausal patients with early breast cancer treated in different countries. | Br J Surg | 2010 |
| 20832103 | Endometrial effects of exemestane compared to tamoxifen within the Tamoxifen Exemestane Adjuvant Multicenter (TEAM) trial: results of a prospective gynecological ultrasound substudy. | Gynecol Oncol | 2010 |
| 19218306 | Effects of exemestane and tamoxifen on bone health within the Tamoxifen Exemestane Adjuvant Multicentre (TEAM) trial: results of a German, 12-month, prospective, randomised substudy. | Ann Oncol | 2009 |
| 19368128 | Adenovirus-mediated thymidine kinase gene therapy induces apoptosis in human epithelial ovarian cancer cells and damages PARP-1. | In Vivo | 2009 |
| 19364653 | The effect of exemestane or tamoxifen on markers of bone turnover: results of a German sub-study of the Tamoxifen Exemestane Adjuvant Multicentre (TEAM) trial. | Breast | 2009 |
| 18589209 | Society of gynecologic oncologists position paper: breast cancer care. | Gynecol Oncol | 2008 |
| 19287072 | Adenovirus-mediated thymidine kinase gene therapy and coxsackie adenovirus receptor expression in ovarian cancer cells. | Cancer Genomics Proteomics | 2008 |
| 19035280 | Persistent adenovirus-mediated thymidine kinase gene expression in ovarian cancer cells increases cell killing efficacy over time. | Anticancer Res | 2008 |
| 18609356 | Post-cesarean adhesions--are they a unique entity? | J Matern Fetal Neonatal Med | 2008 |
| 17595779 | Duration of chemotherapy with topotecan influences survival in recurrent ovarian cancer: a meta-analysis. | Anticancer Res | 2007 |
| 16360811 | Two functionally relevant polymorphisms in the human progesterone receptor gene (+331 G/A and progins) and the predisposition for breast and/or ovarian cancer. | Gynecol Oncol | 2006 |
| 17094433 | Combination of local, non-viral IL12 gene therapy and systemic paclitaxel chemotherapy in a syngeneic ID8 mouse model for human ovarian cancer. | Anticancer Res | 2006 |
| 16886597 | Comparison of ID8 MOSE and VEGF-modified ID8 cell lines in an immunocompetent animal model for human ovarian cancer. | Anticancer Res | 2006 |
| 15726651 | Aberrations in the progesterone receptor gene and the risk of recurrent endometrial carcinoma. | J Pathol | 2005 |
| 15742119 | Midline intravaginal slingplasty for treatment of urinary stress incontinence: results of an independent audit up to 2 years after surgery. | Int Urogynecol J Pelvic Floor Dysfunct | 2005 |
| 15069551 | Expression of splicing factors in human ovarian cancer. | Oncol Rep | 2004 |
| 15579801 | A germline variation in the progesterone receptor gene increases transcriptional activity and may modify ovarian cancer risk. | J Clin Endocrinol Metab | 2004 |
| 15475371 | Functional characterization of somatic point mutations of the human estrogen receptor alpha (hERalpha) in adenomyosis uteri. | Mol Hum Reprod | 2004 |
| 15347897 | Aggressive management of recurrent ovarian cancer--the challenge of individualizing cancer therapy illustrated by a case report. | Onkologie | 2004 |
| 14751192 | Survival after relapse in patients with endometrial cancer: results from a randomized trial. C.L. Creutzberg, W.L.J. van Putten, P.C. Koper, et al., Gynecologic Oncology 89 (2003) 201-209. | Gynecol Oncol | 2004 |
| 14998846 | Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer. | Ann Oncol | 2004 |
| 12796366 | Improvements in quality of life and disease-related symptoms in phase I trials of the selective oral epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in non-small cell lung cancer and other solid tumors. | Clin Cancer Res | 2003 |
| 12969777 | European experience with a novel noninvasive sensor for intra-amniotic or extra-amniotic evaluation of fetal oxygen saturation. | J Soc Gynecol Investig | 2003 |
| 12969718 | A mutated progesterone receptor allele is more prevalent in unexplained infertility. | Fertil Steril | 2003 |
| 12881384 | Multicenter phase II study of oral capecitabine (Xeloda(")) in patients with metastatic breast cancer relapsing after treatment with a taxane-containing therapy. | Ann Oncol | 2003 |
| 14612905 | Tissue and plasma expression of the angiogenic peptide adrenomedullin in breast cancer. | Br J Cancer | 2003 |
| 12810206 | Combination of adenovirus-mediated thymidine kinase gene therapy with cytotoxic chemotherapy in bladder cancer in vitro. | Urol Oncol | 2003 |
| 12771526 | Adnexal masses in pregnancy. | Onkologie | 2003 |
| 11812094 | Evaluation of patients after extraperitoneal lymph node dissection and subsequent radiotherapy for cervical cancer. | Gynecol Oncol | 2002 |
| 12530044 | Experience with the Advanced Breast Biopsy Instrumentation (ABBI) system. | Anticancer Res | 2002 |
| 12409327 | Phase I safety, pharmacokinetic, and pharmacodynamic trial of ZD1839, a selective oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with five selected solid tumor types. | J Clin Oncol | 2002 |
| 11961671 | Intraperitoneal adenovirus-mediated suicide gene therapy in combination with either topotecan or paclitaxel in nude mice with human ovarian cancer. | Cancer Gene Ther | 2002 |
| 12009393 | Adenovirus-mediated thymidine kinase gene therapy for recurrent ovarian cancer: expression of coxsackie-adenovirus receptor and integrins alphavbeta3 and alphavbeta5. | J Soc Gynecol Investig | 2002 |
| 12119458 | Molecular mechanisms in signal transduction: new targets for the therapy of gynecologic malignancies. | Onkologie | 2002 |
| 11860538 | Histologic and immunohistochemical analysis of tissue response to adenovirus-mediated herpes simplex thymidine kinase gene therapy of ovarian cancer. | Int J Gynecol Cancer | 2002 |
| 11455218 | Topotecan chemotherapy in patients with breast cancer and brain metastases: results of a pilot study. | Onkologie | 2001 |
| 11299828 | Immunohistochemical detection of lymph node metastases in node-negative breast cancer patients. | Anticancer Res | 2001 |